Trial Profile
A Phase 1, Open-label, Randomized, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl
- Indications Cancer pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors INSYS Therapeutics, Inc
- 25 Apr 2018 New trial record